🇺🇸 FDA
Patent

US 11801313

Materials and methods for treatment of pain related disorders

granted A61KA61K35/30A61K48/0066

Quick answer

US patent 11801313 (Materials and methods for treatment of pain related disorders) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K35/30, A61K48/0066, A61K9/0019, A61K9/127